Company page
Samsung Biologics Co., Ltd.
Samsung Biologics Co., Ltd. is a leading biopharmaceutical company based in Korea, with a market capitalization of approximately 42.27 trillion KRW. The company specializes in contract manufacturing and offers a range of services for the development and production of biologic drugs. Samsung Biologics is recognized for its advanced facilities and commitment to quality in the biopharmaceutical industry.

- Ticker
- 207940
- Market cap
- $42.27B
- Sector
- Health Technology
- Industry
- Biotechnology